Table 1.

Demographic and clinical characteristics of patients’ and GPs’ total sample, and for patient–GP dyads separately

	Total, n		Dyads, n
	Patient (n = 38)	GP (n = 26)	Patient (n = 20)	GP (n = 14)
Age range, years	30–68	30–64	30–68	30–59
30–39	8	3	4	2
40–49	8	8	5	4
50–59	15	11	7	8
≥60	7	4	4	0
Sex
Female	28	15	15	8
Male	10	11	5	6
Area
Rural	18	8	8	5
Urban	20	18	12	9
Ethnic group		NA		NA
West European	37		19
Non-West European	1		1
Diagnosis		na		na
Anxiety disorder	11		8
Depressive disorder	21		10
Anxiety and depressive disorder	6		2
Antidepressant		na		na
SSRIa	26		11
SNRIb	10		8
TCA	2		1
Experience with discontinuation?c		na		na
Yes, but restarted because of relapse/recurrence	29		16
Yes, but never completely discontinued because of relapse/recurrence	3		1
No	6		3
Duration of antidepressant treatment, yearsd		na		na
1–4	7		3
5–9	8		6
10–14	7		2
15–19	10		7
>19	6		2
Recruited via
GP	20	na	12	na
Patient association	18	na	8	na
Patient	na	10	na	8
GP network	na	16	na	6

^aWith the addition of an atypical antipsychotic (n = 1), methylphenidate (n = 1), or a noradrenergic and specific serotonergic antidepressant (n = 1).

^bWith the addition of lithium (n = 1).

^cAvailable information regarding relapse/recurrence of episodes is insufficiently detailed to differentiate between relapse and recurrence.

^dMost patients using antidepressants for 1–4 years continuously used antidepressants, whereas patients using antidepressants for ≥5 years mostly attempted to discontinue, or discontinued and restarted. na = not applicable. NA = not available. SNRI = serotonin norepinephrine reuptake inhibitor. SSRI = selective serotonin reuptake inhibitor. TCA = tricyclic antidepressant.